These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 31773297

  • 1. Combining DWI radiomics features with transurethral resection promotes the differentiation between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer.
    Xu S, Yao Q, Liu G, Jin D, Chen H, Xu J, Li Z, Wu G.
    Eur Radiol; 2020 Mar; 30(3):1804-1812. PubMed ID: 31773297
    [Abstract] [Full Text] [Related]

  • 2. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F, Barchetti G, De Berardinis E, Pecoraro M, Salvo V, Simone G, Sciarra A, Leonardo C, Gallucci M, Catalano C, Catto JWF, Panebianco V.
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [Abstract] [Full Text] [Related]

  • 3. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
    El-Assmy A, Abou-El-Ghar ME, Refaie HF, Mosbah A, El-Diasty T.
    BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
    [Abstract] [Full Text] [Related]

  • 4. Preoperative Prediction of Muscle Invasiveness in Bladder Cancer: The Role of 3D Volumetric Radiomics Using Diffusion-Weighted MRI, the VI-RADS Score, or a Combination of Both.
    Şam Özdemir M, Azamat S, Özdemir H, Keskin ET, Savun M, Şimşek A, Yardımcı AH.
    Ann Surg Oncol; 2024 Sep; 31(9):5845-5850. PubMed ID: 39003377
    [Abstract] [Full Text] [Related]

  • 5. Value of repeat radical transurethral resection for selected patients with muscle-invasive bladder cancer.
    Li Z, Li Y, Lu Q, Chen J.
    ANZ J Surg; 2018 Oct; 88(10):1033-1036. PubMed ID: 29974604
    [Abstract] [Full Text] [Related]

  • 6. Intravoxel incoherent motion diffusion-weighted imaging in assessing bladder cancer invasiveness and cell proliferation.
    Wang F, Wu LM, Hua XL, Zhao ZZ, Chen XX, Xu JR.
    J Magn Reson Imaging; 2018 Apr; 47(4):1054-1060. PubMed ID: 28815808
    [Abstract] [Full Text] [Related]

  • 7. Elaboration of a multisequence MRI-based radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer: a double-center study.
    Wang H, Xu X, Zhang X, Liu Y, Ouyang L, Du P, Li S, Tian Q, Ling J, Guo Y, Lu H.
    Eur Radiol; 2020 Sep; 30(9):4816-4827. PubMed ID: 32318846
    [Abstract] [Full Text] [Related]

  • 8. Quantitative Identification of Nonmuscle-Invasive and Muscle-Invasive Bladder Carcinomas: A Multiparametric MRI Radiomics Analysis.
    Xu X, Zhang X, Tian Q, Wang H, Cui LB, Li S, Tang X, Li B, Dolz J, Ayed IB, Liang Z, Yuan J, Du P, Lu H, Liu Y.
    J Magn Reson Imaging; 2019 May; 49(5):1489-1498. PubMed ID: 30252978
    [Abstract] [Full Text] [Related]

  • 9. Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
    Koie T, Ohyama C, Hosogoe S, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Mori K.
    Int Urol Nephrol; 2015 Sep; 47(9):1509-14. PubMed ID: 26149637
    [Abstract] [Full Text] [Related]

  • 10. Diffusion kurtosis imaging to assess correlations with clinicopathologic factors for bladder cancer: a comparison between the multi-b value method and the tensor method.
    Wang F, Chen HG, Zhang RY, Jin D, Xu SS, Wu GY, Xu JR.
    Eur Radiol; 2019 Aug; 29(8):4447-4455. PubMed ID: 30666451
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Bladder cancer local staging about muscle invasion: 3.0T MRI performance following transurethral resection].
    Zhao SM, Yang TJ, Xu CM, Guo XF, Ma YK, Chen XJ, Li X, He CH.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug 18; 52(4):701-704. PubMed ID: 32773805
    [Abstract] [Full Text] [Related]

  • 13. Combining Multiparametric MRI Radiomics Signature With the Vesical Imaging-Reporting and Data System (VI-RADS) Score to Preoperatively Differentiate Muscle Invasion of Bladder Cancer.
    Zheng Z, Xu F, Gu Z, Yan Y, Xu T, Liu S, Yao X.
    Front Oncol; 2021 Aug 18; 11():619893. PubMed ID: 34055600
    [Abstract] [Full Text] [Related]

  • 14. Radiomics nomogram for preoperative prediction of progression-free survival using diffusion-weighted imaging in patients with muscle-invasive bladder cancer.
    Zhang S, Song M, Zhao Y, Xu S, Sun Q, Zhai G, Liang D, Wu G, Li ZC.
    Eur J Radiol; 2020 Oct 18; 131():109219. PubMed ID: 32905953
    [Abstract] [Full Text] [Related]

  • 15. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?
    Del Giudice F, Leonardo C, Simone G, Pecoraro M, De Berardinis E, Cipollari S, Flammia S, Bicchetti M, Busetto GM, Chung BI, Gallucci M, Catalano C, Panebianco V.
    BJU Int; 2020 Nov 18; 126(5):610-619. PubMed ID: 32783347
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy.
    Lista F, Andrés G, Cáceres F, Ramón de Fata F, Rodríguez-Barbero JM, Angulo JC.
    Actas Urol Esp; 2013 Nov 18; 37(7):419-24. PubMed ID: 23773823
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Significance of second transurethral resection on patient outcomes in muscle-invasive bladder cancer patients treated with bladder-preserving multimodal therapy.
    Suer E, Hamidi N, Gokce MI, Gulpinar O, Turkolmez K, Beduk Y, Baltaci S.
    World J Urol; 2016 Jun 18; 34(6):847-51. PubMed ID: 26462931
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.